Form 8-K - Current report:
SEC Accession No. 0000950170-25-062913
Filing Date
2025-05-02
Accepted
2025-05-02 17:01:41
Documents
12
Period of Report
2025-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20250430.htm   iXBRL 8-K 55519
2 EX-2.1 rkda-ex2_1.htm EX-2.1 30371
  Complete submission text file 0000950170-25-062913.txt   207053

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20250430.xsd EX-101.SCH 24852
14 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20250430_htm.xml XML 4670
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 25909726
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)